Plasma lipoproteins behave as carriers of extracellular sphingosine 1-phosphate: Is this an atherogenic mediator or an anti-atherogenic mediator?

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1582, Issue 1-3, 2002, Pages 132-137

  Okajima, Fumikazu ^a  

^a GUNMA UNIVERSITY   (Japan)

Author keywords

Atherosclerosis; Edg family receptor; High density lipoprotein; Low density lipoprotein; Oxidized low density lipoprotein; Sphingosine 1 phosphate

Indexed keywords

CARRIER PROTEIN; LIPOPROTEIN; SPHINGOSINE 1 PHOSPHATE;

ANALYTIC METHOD; ATHEROGENESIS; BLOOD ANALYSIS; LIPID ANALYSIS; MEDIATOR; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REVIEW;

ANIMALS; ARTERIOSCLEROSIS; CARRIER PROTEINS; HUMANS; LIPOPROTEINS; LYSOPHOSPHOLIPIDS; SPHINGOSINE;

EID: 0037162038     PISSN: 13881981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1388-1981(02)00147-6     Document Type: Review

References (56)

1. Sphingolipid metabolism and cell growth regulation
2. Functional roles of sphingosine, sphingosine 1-phosphate, and methylsphingosines: In regard to membrane sphingolipid signaling pathways
3. Bioactive lysophospholipids and their G protein-coupled receptors
4. Sphingosine 1-phosphate signalling in mammalian cells
5. Sphingosine-1-phosphate as a ligand for the G protein-coupled receptor EDG-1
6. Comparison of intrinsic activities of the putative sphingosine 1-phosphate receptor subtypes to regulate several signaling pathways in their cDNA-transfected Chinese hamster ovary cells
7. Sphingosine 1-phosphate-induced cell rounding and neurite retraction are mediated by the G protein-coupled receptor H218
8. 2+ signaling pathway
9. Characterization of a novel sphingosine 1-phosphate receptor, edg-8
10. Tumor necrosis factor-alpha induces adhesion molecule expression through the sphingosine kinase pathway
11. High density lipoproteins (HDL) interrupt the sphingosine kinase signaling pathway. A possible mechanism for protection against atherosclerosis by HDL
12. Vascular endothelial cell adherens junction assembly and morphogenesis induced by sphingosine-1-phosphate
13. Sphingosine 1-phosphate stimulates proliferation and migration of human endothelial cells possibly through the lipid receptors, Edg-1 and Edg-3
14. Sphingosine 1-phosphate protects human umbilical vein endothelial cells from serum-deprived apoptosis by nitric oxide production
15. Sphingosine 1-phosphate and isoform-specific activation of phosphoinositide 3-kinase β: Evidence for divergence and convergence of receptor-regulated eNOS signaling pathways
16. Extracellular mechanism through the Edg family of receptors might be responsible for sphingosine-1-phosphate-induced regulation of DNA synthesis and migration of rat aortic smooth-muscle cells
17. Sphingosine-1-phosphate: A platelet-activating sphingolipid released from agonist-stimulated human platelets
18. Sphingosine 1-phosphate, a bioactive sphingolipid abundantly stored in platelets, is a normal constituent of human plasma and serum
19. Interaction of sphingosine 1-phosphate with plasma components, including lipoproteins, regulates the lipid receptor-mediated actions
20. Quantitative measurement of sphingosine 1-phosphate in biological samples by acylation with radioactive acetic anhydride
21. Enzymatic measurement of sphingosine 1-phosphate
22. Quantitative measurement of sphingosine 1-phosphate by radioreceptor-binding assay
23. Sphingosine 1-phosphate may be a major component of plasma lipoproteins responsible for the cytoprotective actions in human umbilical vein endothelial cells
24. The pathogenesis of atherosclerosis: A perspective for the 1990s
25. Low density lipoprotein oxidation and its pathobiological significance
26. Antioxidants and atherosclerotic heart disease
27. Atherosclerosis - An inflammatory disease
28. Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyte/endothelial interactions and evidence for their presence in vivo
29. Oxidized low density lipoprotein induces apoptosis in cultured human umbilical vein endothelial cells by common and unique mechanisms
30. Lysophosphatidylcholine: A chemotactic factor for human monocytes and its potential role in atherogenesis
31. 2 activity of apoprotein B-100
32. Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells
33. Oxidized LDL activates fas-mediated endothelial cell apoptosis
34. Oxidized LDL regulates macrophage gene expression through ligand activation of PPARγ
35. Oxidatively modified LDL contains phospholipids with platelet-activating factor-like activity and stimulates the growth of smooth muscle cells
36. Lysophosphatidic acid mediates the rapid activation of platelets and endothelial cells by mildly oxidized low density lipoprotein and accumulates in human atherosclerotic lesions
37. Lysophosphatidylcholine as a ligand for the immunoregulatory receptor G2A
38. Evidence that lipoproteins are carriers of bioactive factors
39. Activation of phosphatidylinositol-specific phospholipase C by HDL-associated lysosphingolipid: Involvement in mitogenesis but not in cholesterol efflux
40. Suppression of endothelial cell apoptosis by high density lipoproteins (HDL) and HDL-associated lysosphingolipids
41. Regulatory effects of HDL on smooth muscle cell prostacyclin release
42. Sphingomyelin metabolites in vascular cell signaling and atherogenesis
43. Lysophosphatidic acid and sphingosine 1-phosphate: Two lipid villains provoking cardiovascular diseases?
44. Role of sphingosine 1-phosphate in the mitogenesis induced by oxidized low density lipoprotein in smooth muscle cells via activation of sphingomyelinase, ceramidase, and sphingosine kinase
45. Sphingosine-1-phosphate inhibits PDGF-induced chemotaxis of human arterial smooth muscle cells: Spatial and temporal modulation of PDGF chemotactic signal transduction
46. Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate
47. Sphigosine 1-phosphate induces platelet activation through an extracellular action and shares a platelet surface receptor with lysophosphoatidic acid
48. Identification of lysophospholipid receptors in human platelets: The relation of two agonists, lysophosphatidic acid and sphingosine 1-phosphate
49. Cholesterol and phospholipid metablism in macrophages
50. Release of cellular cholesterol: Molecular mechanism for cholesterol homeostasis in cells and in the body
51. Cellular and physiological roles of SR-BI, a lipoprotein receptor which mediates selective lipid uptake
52. Atheroprotective mechanisms of HDL
53. Induction by lysophosphatidylchline, a major phospholipid component of atherogenic lipoproteins, of human coronary artery smooth muscle cell migration
54. HDL and apoA prevent cell death of endothelial cells induced by oxidized LDL
55. High-density lipoprotein stimulates endothelial cell movement by a mechanism distinct from basic fibroblast growth factor
56. High-density lipoprotein binding to scavenger recetor-BI activates endothelial nitric oxide synthase